WednesdayNov 13, 2024 8:00 am

13th Annual ROTH Technology Event Opens Doors to Investor Opportunities

The 13th Annual ROTH Technology Conference, hosted by investment bank Roth Capital Partners, is set to bring together innovative technology companies and investors on November 19-20, 2024, at the Hard Rock Hotel in New York City. This exclusive, by-invitation-only event will provide a focused platform for capital sources and entrepreneurs to connect, explore potential partnerships, and pursue financial growth opportunities in the technology industry. Approximately 100 growth-oriented technology companies will be represented by their executive teams, with an additional dozen companies invited to participate. Attendees will engage in 40-minute, pre-arranged one-on-one and small-group meetings to discuss investment opportunities, capped by…

Continue Reading

TuesdayNov 12, 2024 3:18 pm

QualityStocksNewsBreaks – SportLync, Inc. Changes Name, Raises Crowdfunding Ceiling to Drive Evolution to Multisport Platform

SportLync, formerly known as GolfLync, today announced a change in its name from GolfLync to SportLync, Inc., as well as an increase in its crowdfunding goal to $5 million. The capital raise, initially launched to allow users and supporters to invest in the platform, is part of a larger strategy to expand the company’s unique social networking model beyond golf to other sports. While the GolfLync app will continue to connect golf players across the country, SportLync is working on plans to bring similar community experiences to fans and athletes in other sports. “We launched our crowdfunding campaign to give…

Continue Reading

TuesdayNov 12, 2024 9:30 am

Kairos Pharma Ltd. (NYSE American: KAPA) Is ‘One to Watch’

Kairos Pharma’s partnership with Cedars-Sinai Medical Center enhances clinical trial efficiency and accelerates the development of new therapeutic solutions. The company holds a robust intellectual property portfolio with patents extending through 2040, providing a strong competitive advantage in the oncology market. ENV105, Kairos’s lead drug candidate, shows promise in reversing drug resistance in prostate and lung cancers, addressing key markets with high demand for novel treatments. Positioned in high-growth oncology segments, Kairos Pharma meets substantial market needs, driven by the increasing global incidence of drug-resistant cancers. The company’s focus on biomarker development improves patient targeting, enhancing therapy success rates and…

Continue Reading

TuesdayNov 12, 2024 8:45 am

SOBRsafe Inc. (NASDAQ: SOBR) Raises $8.2M in Private Placement Offering Amid Ongoing Expansion Efforts, Marketing Campaign to Drive Growth

Alcohol screening and monitoring solutions provider SOBRsafe recently closed on a private placement, which raised $8.2 million in gross proceeds The company plans to use the net proceeds from the private placement for working capital and general corporate purposes, including possibly boosting its expansion efforts With an ongoing national marketing campaign, SOBRsafe is presenting its revolutionary alcohol screening and monitoring technologies to 45,000 behavioral health providers in the U.S. In addition, the company initiated sales activities in Australia and New Zealand through a partnership with a channel partner, and is partnering with companies in India and Italy for proof-of-concept installations…

Continue Reading

TuesdayNov 12, 2024 8:20 am

QualityStocksNewsBreaks – Annovis Bio Inc. CEO to Showcase Buntanetap’s Dual Benefits for Alzheimer’s and Parkinson’s at NIA Workshop

Annovis Bio (NYSE: ANVS) announced that its President and CEO, Dr. Maria Maccecchini, will speak at the National Institute on Aging’s (NIA) workshop, “Dementia with Lewy Bodies: Filling the Gaps in Translational and Clinical Research.” Scheduled for Nov. 13, 2024, Dr. Maccecchini’s presentation, titled “One Drug, Dual Effect: Buntanetap Improves Cognitive and Motor Functions, Benefiting Alzheimer's and Parkinson's Patients. A Potential Path for Lewy Body Dementia?” will explore the potential of Annovis’s lead drug candidate, Buntanetap, to address neurodegenerative diseases by enhancing cognitive and motor functions, with implications for Lewy body dementia treatment. To view the full press release, visit…

Continue Reading

TuesdayNov 12, 2024 8:15 am

QualityStocksNewsBreaks – Fathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) Expands Private Placement Offering with Flow-Through Units Amid Strong Demand

Fathom Nickel (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) has amended its private placement offering by introducing a flow-through unit (“FT Unit”) component at $0.04 per unit, responding to high investor interest. Additionally, the price of hard dollar units (“HD Units”) has been adjusted to $0.035 per unit. The offering is expected to raise approximately $750,000, with proceeds allocated for Canadian exploration expenses under the Income Tax Act and exploration at the Gochager Lake Project in Saskatchewan. Closing is anticipated by Nov. 21, 2024, pending regulatory and Canadian Securities Exchange approvals. To view the full press release, visit https://ibn.fm/6TNuD About Fathom…

Continue Reading

TuesdayNov 12, 2024 8:00 am

AI Solutions Startup Secures $15m in Fundraising Round

Cogna, an artificial intelligence software firm, just brought in $15 million in new backing. The company has the largest gas distribution network in Britain among its clients. This latest funding includes investment from key venture capital firms Chalfen Ventures and Notion Capital. Cogna intends to use the funding to boost productivity and resolve inefficiencies within the operations of their target clientele. According to the company, they intend to use “precision solutions” in the diagnosis and fixing of those challenges faced by their customers. Their clients are currently within the manufacturing, utilities and energy sectors. With this new funding, Cogna plans…

Continue Reading

MondayNov 11, 2024 3:43 pm

QualityStocksNewsBreaks – Torr Metals Inc. (TSX.V: TMET) Unlocking Unexplored Regions for New Copper and Gold Discoveries

Torr Metals Inc. (TSX.V: TMET), a Vancouver-based mineral exploration company, is pursuing cost-effective strategies with higher potential for returns, focusing on district-scale areas with low exploration maturity and strong prospects for new copper and gold discoveries. “With 100% ownership of nearly 1,200 km², Torr’s projects enjoy direct highway access, proximity to power grids, and established mining infrastructure, allowing operations near local towns and cities. In short, Torr is unlocking underexplored regions with major discovery potential, where operation costs are low and mining giants are already invested with dwindling mines that will require feed,” reads a recent article. “My background is…

Continue Reading

MondayNov 11, 2024 3:40 pm

QualityStocksNewsBreaks – Aegis Capital Corp. Acts as Agent on $9.15M Private Placement for Zoomcar Holdings Inc. (NASDAQ: ZCAR)

Aegis Capital Corp. has been in the wealth management and investment banking business since 1984 and is dedicated to providing corporate finance, strategic advisory and related services to public and private companies across multiple sectors and regions. Aegis has announced that it acted as exclusive placement agent on a $9.15 million private placement for Zoomcar Holdings (NASDAQ: ZCAR). According to ZCAR, the company used the net proceeds from the private placement to repay approximately $3.8 million of outstanding indebtedness to certain institutional investors and intends to use the remainder for general corporate purposes and working capital. To view the full…

Continue Reading

MondayNov 11, 2024 2:40 pm

QualityStocksNewsBreaks – SOBR Safe Inc. (NASDAQ: SOBR) Continues to Gain Traction, Further International Growth

SOBR Safe (NASDAQ: SOBR) (“SOBRsafe”) develops and sells a passive, preventative alcohol screening device called the SOBRcheck(TM) and a continuous alcohol monitoring wristband called SOBRsure(TM). “SOBRcheck is fitted with two sensors, one of which scans biometrics data from a user’s fingerprint, with the other detecting any alcohol excreted from the pores in the tip of the finger. The device is powered by the SOBRsafe software platform, which relays results in real time, improving employee throughput at point-of-care facilities. The SOBRsure(TM) device is equally configured to provide app-based reporting via the SOBRsafe platform, support GPS tracking and send removal alerts,” a…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered